Free tool
Heavily traded stocks
We cover 21 companies whose typical session turns over more than $10.00M. The median market value in the group is $3.12B. Across the group, the median move over the past trading day is 0.00%. Price change over the past year runs from −26.6% to +145.3% across the middle 80 percent of the group, with a median of +6.0%.
Other lists in this group
Table
21 of 7,336 companies match these filters.Clear filters
| Ticker | Company | Market cap (USD) | Size | 1Y return | Next report |
|---|---|---|---|---|---|
| CHE | Chemed Corporation | $7.11B | Mid cap | +20.79% | Oct 27, 2026 |
| GETI-B.ST | Getinge AB (publ) | $7.01B | Mid cap | +20.89% | Oct 21, 2026 |
| 3391.T | Tsuruha Holdings Inc. | $6.89B | Mid cap | +5.97% | Oct 9, 2026 |
| 0126Z0.KS | SAMSUNG EPIS HOLDINGS | $6.82B | Mid cap | +15.35% | Oct 23, 2026 |
| KNSA | Kiniksa Pharmaceuticals International, plc | $6.05B | Mid cap | +133.47% | Oct 27, 2026 |
| SECT-B.ST | Sectra AB (publ) | $5.63B | Mid cap | −17.02% | Sep 4, 2026 |
| MMED | MiniMed Group, Inc. | $5.48B | Mid cap | +5.41% | Sep 1, 2026 |
| RCUS | Arcus Biosciences, Inc. | $3.92B | Mid cap | +191.29% | Oct 27, 2026 |
| 3349.T | COSMOS Pharmaceutical Corporation | $3.26B | Mid cap | −26.59% | Oct 13, 2026 |
| 7649.T | Sugi Holdings Co.,Ltd. | $3.13B | Mid cap | −28.60% | Oct 8, 2026 |
| ARQT | Arcutis Biotherapeutics, Inc. | $3.12B | Mid cap | +60.64% | Oct 27, 2026 |
| HYPE3.SA | Hypera S.A. | $2.98B | Mid cap | −4.69% | Oct 27, 2026 |
| NRIX | Nurix Therapeutics, Inc. | $2.77B | Mid cap | +179.69% | Oct 8, 2026 |
| WGS | GeneDx Holdings Corp. | $2.69B | Mid cap | −30.11% | Oct 27, 2026 |
| NEOG | Neogen Corporation | $2.54B | Mid cap | +103.83% | Oct 8, 2026 |
| ATRC | AtriCure, Inc. | $2.45B | Mid cap | +29.14% | Oct 27, 2026 |
| 3549.T | Kusuri No Aoki Holdings Co., Ltd. | $2.44B | Mid cap | +5.23% | Oct 1, 2026 |
| NEO | NeoGenomics, Inc. | $2.26B | Mid cap | +145.34% | Oct 27, 2026 |
| 302440.KS | SK bioscience Co.,Ltd. | $2.18B | Mid cap | −20.29% | Oct 26, 2026 |
| ALIF-B.ST | AddLife AB (publ) | $2.08B | Mid cap | −7.20% | Oct 21, 2026 |
| GNS.L | Genus plc | $2.08B | Mid cap | −12.94% | Sep 10, 2026 |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.